RxDoctor Payments Data

Judith Mattox, NP

Nurse Practitioner · Palos Heights, ILNPI 1841629821

Payments from drug & device makers

$1,318in general payments, 2019–2025

Across 64 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$347
  • Sumitomo Pharma America, Inc.$269
  • Astellas Pharma US Inc$122
  • 180 Medical, Inc.$113
  • Urovant Sciences Inc$95
  • Axonics, Inc.$85
  • plus $288 from 8 others

What the payments were for

  • Food & beverage$1,21592%
  • Education$1038%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,318 in reported general payments places this provider in the 85th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$128,165
Medicare patients
520
Services billed
1,535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron203$142,191
MyrbetriqMirabegron102$60,168
OrgovyxRelugolix23$58,292
Tamsulosin Hcl545$6,664
Oxybutynin Chloride ErOxybutynin Chloride157$3,962
Solifenacin Succinate41$2,840
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst92$1,622
Finasteride88$1,524
NitrofurantoinNitrofurantoin Macrocrystal62$1,521
Tolterodine Tartrate ErTolterodine Tartrate17$1,496
Desmopressin Acetate25$1,412
Trimethoprim19$680
Cephalexin69$344
Alfuzosin Hcl ErAlfuzosin Hcl15$296
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim79$261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa, Orgovyx$269$200,483226 claims
Astellas Pharma US IncMyrbetriq$122$60,168102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Palos Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →